Novo Nordisk público
[search 0]
Mais
Download the App!
show episodes
 
Artwork

1
Acquired

Ben Gilbert and David Rosenthal

Unsubscribe
Unsubscribe
Mensal
 
Every company has a story. Learn the playbooks that built the world’s greatest companies — and how you can apply them as a founder, operator, or investor.
  continue reading
 
Artwork

1
Unhedged

Financial Times & Pushkin Industries

Unsubscribe
Unsubscribe
Semanal+
 
Katie Martin, Robert Armstrong and other markets nerds at the Financial Times explain the big ideas behind what’s happening in finance right now. Every Tuesday and Thursday. Hosted on Acast. See acast.com/privacy for more information.
  continue reading
 
Artwork

1
ACQ2 by Acquired

Ben Gilbert and David Rosenthal

Unsubscribe
Unsubscribe
Mensal
 
ACQ2 is Ben and David's conversations with expert founders and investors. Acquired the stories of great companies — and ACQ2 dives deeper into the lessons we can learn from them, often with the protagonists themselves.
  continue reading
 
Artwork

1
Ask the Experts: It's Personal

American Diabetes Association

Unsubscribe
Unsubscribe
Mensal
 
Ask the Expert’s: It’s Personal features real questions from people with diabetes and answers from diabetes experts. Please join us for this Q&A series to hear practical tips on topics such as nutrition, medication management, and physical activity. This podcast series is brought to you through our Know Diabetes by Heart and Focus on Diabetes initiatives. If you have type 2 diabetes, your risk of developing cardiovascular disease is doubled. The American Diabetes Association, in collaboratio ...
  continue reading
 
Welcome to 7investing.com. Our mission is to empower you to invest in your future. This podcast brings our market-based experts together to discuss our investing process and important news. Once a month, we will also feature interviews with some of the best minds in business and investing. Check out 7investing.com to find more of our free content and premium monthly stock recommendations.
  continue reading
 
I'm passionate about helping pharma field teams feel confident using technology to engage with healthcare professionals. I want them to feel good about themselves and achieve amazing results. To explore this topic, I've been interviewing inspiring pharma leaders to learn from them for this Digital Transformation Series. - Mehrnaz Campbell, Founder and CEO of Cheemia & Cheemia ReSET Author of The Omni Advantage
  continue reading
 
Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD discuss important head-to-head data between a GLP-1 RA and DPP-4 inhibitor as an important consideration when making clinical decisions for patients with T2D. Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two oral antidiabetic therapies. Episode 3: Hear this clinical panel share a quick overview of the patient support resources availabl ...
  continue reading
 
Artwork
 
About Strategy Sprints Podcast Strategy Sprints is the CEO source for actionable growth strategies. Bucking the trend of boring meetings and late reports, host Simon Severino helps you to run your business at it’s highest level of effectiveness. These daily CEO Tips are short, impactful and perfect for your commute or workout. Visit www.strategysprints.com for more info on how a 1:1 sprint coach can help you double revenues in 90 days. Hosted by Simon Severino and the Strategy Sprints team. ...
  continue reading
 
Artwork

1
Know Diabetes by Heart™ Professional Education Podcast Series

American Heart Association and American Diabetes Association

Unsubscribe
Unsubscribe
Mensal
 
The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The Am ...
  continue reading
 
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
  continue reading
 
Artwork
 
Replenish your inner leader with our executive elixir of wisdom, humor, and the power of human connection. CEO and vocal leadership expert Tina Dietz and her guests guide you through the dark forest of professional development to ignite your managerial magic with discussions on the most important topics we're facing in the workplace today. Visit http://DrinkFromTheWellPodcast.com for show notes, transcripts, and insights. About Your Host: Tina Dietz is the CEO of Twin Flames Studios—a full-s ...
  continue reading
 
Work in Progress – People & Culture (P&C) - is a talk series that features thought leaders from the P&C and HR industries. Session's CEO Pernille Brun leads these discussions to uncover the latest trends shaping the future of work and the evolving landscape of P&C. Through these sessions, we explore how P&C and HR can effectively support organizations, leaders, and employees to adapt to the changing demands of the workforce. We also delve into what strategies P&C departments can implement to ...
  continue reading
 
Artwork

1
OFF BIKE - CHPT3 Sporting Club

David Millar and Mikkel B. Rasmussen

Unsubscribe
Unsubscribe
Mensal
 
OFF BIKE - A Podcast About Where Cycling Takes Us What happens when you get off the bike? Join the ex pro rider David Millar and the business anthropologist Mikkel B. Rasmussen while they explore what biking does for us beyond the ride. The question might sound banal, but it is actually not so easy to answer. David and Mikkel outline their ambitious plans for this brand new series of podcasts where they will interview a wide cross-section of people to investigate their journeys through life ...
  continue reading
 
As President of the International Institute for Management Development - better known as IMD - Jean-François Manzoni has a direct line to some of the world’s most interesting and successful business leaders. In this new podcast, he shares that opportunity with you.In each episode, we’ll hear from a different CEO about the path that brought them to the C-suite, the insights they’ve gained at the top -- and the advice they’d like to pass on to the next generation.New episodes every other Thursday.
  continue reading
 
An in-depth look at how ultra-endurance events place extreme and unique physiological demands on athletes. This podcast will feature athletes, and their support teams, talking about how they prepare and compete at the world's toughest events. Expect discussion around long-term preparation, nutrition, coping with environmental stressors and building psychologic toughness! Host: Nick Longworth has been hosting international sports technology and life science conferences for the last decade, an ...
  continue reading
 
An inspiring and informational podcast for women ready to level up in all areas of their lives- whether it's with health, money, mindset, career, relationships, lifestyle and more. Ana offers insight, resources and practical tools that positively impact personal and business finances, home life, career, health and wellness for Women Warriors of every kind! Go on a very real-talk journey with Ana as she interviews coaches and subject matter experts on this variety of topics and join a communi ...
  continue reading
 
Welcome to Pharma Launch Secrets, a podcast by Evermed. We host honest, direct, actionable conversations with world-leading pharma launch experts that will help you stay up to date with trends and strategies to help you launch your product successfully.
  continue reading
 
Join Ankita a.k.a the HR Bandit for a fun-filled conversation on what’s happening around the world and its impact on how we work. News, events, research, crazy ideas, and work experiments – this podcast covers it all. So, grab a cup (glass) of coffee (wine), sit back, and enjoy the banter. The podcast is a part of the new workplace initiative and sponsored by the kind folks over at NHRDN Hyderabad. All views, expressed are that of the speakers and are not the positions, strategies, or opinio ...
  continue reading
 
Artwork
 
Welcome to the All Fired Up podcast, with your host Louise Adams! Louise is by nature a mild mannered clinical psychologist, but her alter ego – a FIERCE and fearless anti-diet crusader – is taking over! Louise specialises in helping people recover from disordered eating, and she’s COMPLETELY OVER trying to help people when the culture we live in is utterly sick, toxic, and screwed up when it comes to food, exercise, health, and body size. Louise cannot for a second longer take the rampant i ...
  continue reading
 
Loading …
show series
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. A study has found that Novo Nordisk's semaglutide may reduce the risk of Alzheimer's disease by 40% to 70%. Roche has entered a potential $1 billion gene therapy deal with Dyno Therapeutics, focusing on neurological diseas…
  continue reading
 
Eli Lilly’s shares have surged 750 per cent over five years. Novo Nordisk’s are up about 360 per cent in the same period. It's been an awesome run for these companies. But how much longer can it last? Today on the show, Rob Armstrong and Aiden Reiter talk to the FT’s US pharmaceutical and biotech correspondent Oliver Barnes about the astonishing gr…
  continue reading
 
Unlock the secrets to fostering a strong organizational culture with our special guest, Michael Frantl, Global Culture, Engagement & Performance Solutions Lead at Novo Nordisk. Michael shares his expertise on maintaining a strong cultural identity amidst rapid company growth and leveraging hybrid and flexible work conditions to enhance employee eng…
  continue reading
 
As betting markets and polls begin tentatively to suggest a Donald Trump election win, yields in 10-year Treasuries have risen. Some on Wall Street think that is because traders believe Trump will win, bringing with him inflationary spending and policies. Today on the show, Rob Armstrong discusses what the bond market knows with Derek Brower, the F…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche CEO opposes Novo Holdings' acquisition of Catalent, urging for it to be blocked. Roche exceeded Q3 sales expectations, driven by the success of drugs like Ocrevus and Vabysmo. Pfizer's RSV vaccine has been approved …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche has ended its collaboration with UCB on Alzheimer's treatments, marking the third candidate dropped by Roche this year. Meanwhile, activist investor Starboard has set its sights on Kenvue, a division of J&J, follow…
  continue reading
 
Citadel, XTX and Jane Street have come to dominate trading on Wall Street, and not just in equities. They now run a huge proportion of trading in currency and bonds, something the banks used to own. But where did they come from, why have so few people heard of them, and how did they get so big? Today on the show, Katie Martin and Robin Wigglesworth…
  continue reading
 
Email me - severino@strategysprints.com🏡🛥🐬Dive into the fascinating world of Financial Freedom and High-Ticket Sales! 🌟With over two decades of experience and responsible for over $2 Billion in additional sales for my clients, I bring you insider knowledge and exclusive insights.In this channel, you'll discover:🌞 Financial Freedom: A life on your t…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer ResearchIn a groundbreaking study published in Nature Medicine, researchers have identified a new potential target for cancer therapy. This discovery could lead to more effective treatments for a…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves AbbVie 24-hour Parkinson’s treatment The bad — Sage Therapeutics axes workforce The ugly — FDA halts Novavax's COVID-flu vaccine trialsPor Pharma Manufacturing
  continue reading
 
The Dutch lithography juggernaut ASML (Nasdaq: ASML) has been one of the semiconductor industry's best performing stocks of the past decade. Yet its high-flying shares have sold off 33% in the past three months, perhaps due to its underwhelming forward guidance that could indicate slowing demand. ASML has looked to Intel (Nasdaq: INTC) for much of …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## New Drug Approval: Title: FDA Approves New Cancer Drug for Treatment of Breast CancerContent: The FDA has approved a new cancer drug for the treatment of breast cancer. This new drug is expected to provide better outc…
  continue reading
 
I talk to Marco Andre, Global Head of AI and Marketing Excellence at Novartis. I was particularly excited because Marco is quite unique. He possesses extensive experience in AI and automation, yet he brings a refreshing humility to how these tools can be applied in the pharmaceutical industry. Marco is a keynote speaker, an AI advisor to executives…
  continue reading
 
Lululemon (Nasdaq: LULU) has expanded from being a niche yoga retailer to an international fitness super-brand. New CEO Calvin McDonald has tripled its sales in five years and maintained its industry-leading 20% operating margin. Yet recently, perhaps due to concerns of a slowdown in consumer spending or of rising competition, the stock has been se…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Sanofi has signed a $326 million deal with Orano Med for radiopharma, following a similar deal made in September. Sage Therapeutics is laying off 33% of employees to support the launch of its postpartum depression drug. …
  continue reading
 
Nicolai Tangen oversees Norges Bank Investment Management, also known as Norway’s oil fund. It contains about $2tn in assets, based on money earned from drilling for oil offseas. Today on the show, Tangen talks with Katie Martin about everything from the European economy to China and Taiwan to overconcentration in the American stock markets. Also, …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA has paused Novavax's investigational flu and COVID-flu vaccines due to a serious adverse event of motor neuropathy. This affects their COVID-flu combo and standalone flu vaccines, which were about to enter phase I…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##Breaking News: FDA Approves New Cancer DrugIn a groundbreaking development, the FDA has approved a new cancer drug that has shown promising results in clinical trials. The drug is expected to provide hope for patients w…
  continue reading
 
Grouping the majority of the world’s economies into a basket labelled “emerging markets” and trying to generalise about them is a fool’s errand. And we are perfect for the job. Today on the show, Katie Martin and Aiden Reiter discuss the EM landscape and pay particular attention to Brazil’s hot economy. Also we go long Poppy Gustafsson and short Ne…
  continue reading
 
Email me - severino@strategysprints.com🏡🛥🐬Dive into the fascinating world of Financial Freedom and High-Ticket Sales! 🌟With over two decades of experience and responsible for over $2 Billion in additional sales for my clients, I bring you insider knowledge and exclusive insights.In this channel, you'll discover:🌞 Financial Freedom: A life on your t…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Danish pharmaceutical company Lundbeck has announced a $2.6 billion deal to acquire Longboard Pharmaceuticals, gaining access to their epilepsy drug currently in late-stage development. The FDA's accelerated approval pathwa…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Roche snags breast cancer FDA nod The bad — FDA places clinical hold on Kezar lupus nephritis drug trial The ugly — FDA rejects Zealand Pharma hypoglycemia drug over manufacturing reinspection…
  continue reading
 
We sit down with Hugging Face CEO Clem Delangue to understand the current state of the open source AI ecosystem. Hugging Face is the leading platform to host and collaborate on AI models, datasets, and applications. They also have a compute offering for AI builders to train their models directly on the platform. Clem has a contrarian take on the fu…
  continue reading
 
In this episode, Ditte Buch Andersen offers valuable insights into the process of identifying the right company values and how linking those values to specific animals can make them stronger and more memorable. In the case of the company Neurons, the elephant, gazelle, and zebra represent integrity, growth, and responsibility, respectively, sparkin…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche has received regulatory approval for its breast cancer drug, inavolisib, for advanced breast cancer, projecting $2.3 billion in peak sales. This drug is seen as a potential competitor to Novartis' pi3k inhibitor piq…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.GSK has settled Zantac lawsuits for $2.2 billion, resolving 93% of product liability cases regarding allegations that the heartburn drug could cause cancer. Analysts are now shifting focus to the company's vaccines busine…
  continue reading
 
Aprende cómo la nueva tecnología, como los monitores continuos de glucosa (CGM) o las bombas de insulina, puede ayudar a manejar la diabetes. Descubre qué debes preguntar en tu próxima visita con tu proveedor de salud para encontrar la tecnología que mejor se adapte a ti. Ven preparado con preguntas para nuestra experta, Amy Butts, PA, como: “¿Podr…
  continue reading
 
Listeners called in and asked our experts questions about how new technology, like a continuous glucose monitor (CGM) or insulin pump, can be used to manage diabetes. Listen to our Ask the Experts event to learn how to reduce your risk of heart disease, stroke, and kidney disease when living with type 2 diabetes. Find more helpful resources on the …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.This week's commercialization news includes updates on Zepbound supply, Enjaymo's new home, and expanding access to HIV drugs. Medicare has tweaked rules for drug price talks, while GSK reports that its RSV vaccine protects…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Sage has decided to discontinue the development of its Alzheimer's drug candidate, dalzanemdor, after disappointing mid-stage readouts. This is the third setback in neurology for the company in six months. Meanwhile, cell a…
  continue reading
 
What do self-driving cars, Jensen Huang, McDonald's drive-through and Mark Zuckerberg all have in common? Nick Griffin talks about their impact on growth investing in the latest episode of our Invest in the Journey Podcast. Join us for this episode with Founding Partner and CIO Nick Griffin, who gives us the rundown of his recent research trip to t…
  continue reading
 
Stocks are flying, rates are plunging, jobs are surging, but everyone says they’re anxious. What is going on? Today on the show, Katie Martin and Rob Armstrong try to understand the many strange and sometimes contradictory things happening in the US economy. Also, we go short Spirit Halloween and long monsters. For a free 30-day trial to the Unhedg…
  continue reading
 
Email me - severino@strategysprints.com🏡🛥🐬Dive into the fascinating world of Financial Freedom and High-Ticket Sales! 🌟With over two decades of experience and responsible for over $2 Billion in additional sales for my clients, I bring you insider knowledge and exclusive insights.In this channel, you'll discover:🌞 Financial Freedom: A life on your t…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Scholar Rock has achieved success in a drug study for spinal muscular atrophy, potentially setting a new standard for treatment. Judo Bio has debuted with $100 million funding to develop RNA drugs for kidney targets. Intell…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Gilead inks deal with generics manufacturers to expand HIV drug access The bad — J&J announces layoffs at New Brunswick headquarters The ugly — Amgen sued for hiding $10.7B tax bill…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.CVS is laying off 2,900 employees as part of a cost-cutting plan and potential business breakup. Humana's Medicare Advantage star ratings have dropped significantly, impacting profits. Healthcare workers face burnout, whi…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The FDA decisions to watch from October 3-5 include the approval of a rival to a fast-selling Pfizer heart drug, a lung cancer medicine, and an addition to Vertex's cystic fibrosis business. Prime is narrowing its gene e…
  continue reading
 
As the conflict in the Middle East expands to include Lebanon and Iran, markets are responding with surprising nonchalance. Why? And will that last? Today on the show, Katie Martin and capital markets correspondent Nick Megaw try to understand why so much can go wrong in one part of the world, without roiling markets in the rest of the world. Also,…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Bayer has developed a successful audience targeting strategy that drives meaningful engagement, with Crossix audience segments optimizing campaigns and aligning messaging more closely with the patient journey. This precisi…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Artificial intelligence (AI) has the potential to revolutionize clinical trials, particularly in site identification and patient recruitment. AI can address longstanding challenges in clinical research, offering a four-part…
  continue reading
 
Our newest stock recommendation is now live! On the 1st of each month, 7investing issues its newest official recommendation. This is the one stock it feels most confident in adding to its scorecard (which we also track in real-time at 7investing.com/recommendations). What led us to recommend this Large Cap, Moderate Risk, Retail company this month?…
  continue reading
 
Last week China announced it would be providing low-cost funds to investors in both equities and the property market. The nominal effects were immediate, and the country’s stock market has recently risen as much as 20 per cent. Boosting stock prices is one thing, but there is a bigger problem: can Beijing encourage more domestic spending, and less …
  continue reading
 
Email me - severino@strategysprints.com🏡🛥🐬Dive into the fascinating world of Financial Freedom and High-Ticket Sales! 🌟With over two decades of experience and responsible for over $2 Billion in additional sales for my clients, I bring you insider knowledge and exclusive insights.In this channel, you'll discover:🌞 Financial Freedom: A life on your t…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche's investment in startup Regor Therapeutics for a new breast cancer drug, worth $850 million, shows their commitment to innovative research. Prime's focus on gene editing research and partnership with Bristol Myers …
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good —FDA approves BMS schizophrenia drug The bad — bluebird bio announces layoffs The ugly —J&J talc subsidiary files for bankruptcyPor Pharma Manufacturing
  continue reading
 
Here it is: the complete video of the most unbelievable night of Acquired’s nine-year life… our sold out live show at the Chase Center in San Francisco. We joked during the months (months!) of preparation leading up to this event that it was like planning a wedding for 6,000 Acquired fans, and the guest list included Jamie Dimon, Daniel Ek, Emily C…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Bristol Myers has received approval for a first-of-its-kind schizophrenia drug, Cobenfy, and plans to sell it despite potential insurance barriers for patients. Biogen and UCB are planning a large study for their lupus medi…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Democrats have introduced a bill to make increased Affordable Care Act (ACA) subsidies permanent, arguing that if the enhanced tax credits expire, healthcare costs for millions of Americans will suddenly increase. Meanwhil…
  continue reading
 
Loading …

Guia rápido de referências